Australia markets closed

Starpharma Holdings Limited (SPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1350+0.0100 (+8.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
2,939
2,939
4,682
1,798
6,033
Cost of revenue
1,120
1,120
2,776
791
890
Gross profit
1,819
1,819
1,906
1,007
5,143
Operating expenses
Research development
11,239
11,239
11,680
15,075
14,808
Selling general and administrative
3,768
3,768
3,292
4,017
2,669
Total operating expenses
20,055
20,055
19,618
23,362
21,814
Operating income or loss
-18,236
-18,236
-17,712
-22,355
-16,671
Total other income/expenses net
559
135
263
1,336
559
Income before tax
-15,638
-15,638
-16,154
-19,732
-14,678
Income tax expense
0
0
0
0
0
Income from continuing operations
-15,638
-15,638
-16,154
-19,732
-14,678
Net income
-15,638
-15,638
-16,154
-19,732
-14,678
Net income available to common shareholders
-15,638
-15,638
-16,154
-19,732
-14,678
Basic EPS
-0.04
-
-0.04
-0.05
-0.04
Diluted EPS
-0.04
-
-0.04
-0.05
-0.04
Basic average shares
409,035
-
406,900
396,876
372,232
Diluted average shares
409,035
-
406,900
396,876
372,232